Canadian Plasma Clinics Halt Operations After Two Donor Deaths Amid Scrutiny

A major shake-up in Canada's plasma collection industry has seen Grifols, a Spanish healthcare giant, temporarily close all 17 of its Canadian clinics, including those in Calgary, following the deaths of two donors. The company claims the shutdown is due to 'unfounded attention,' but it comes as Health Canada, the country's federal health regulator, intensifies its investigation into alleged safety failures and issued a non-compliance rating to one of Grifols' Winnipeg clinics just days ago. This dramatic halt, which began Friday, leaves questions swirling about the safety protocols for paid plasma collection across the country. The sudden pause follows the deaths of two individuals, including 22-year-old international student Rodiyat Alabede, who experienced distress during their plasma donation in Winnipeg in October 2025 and January 2026. While Health Canada initially found no direct link between the deaths and the donation process, patient advocates, like the Manitoba Health Coalition, have strongly criticized Grifols' for-profit model, arguing it prioritizes cost-cutting over donor safety. Federal data reveals a concerning pattern, with 25 serious adverse reactions reported at Grifols' Canadian centers since 2018, and recent inspections highlighting problems with donor screening and staff training. Grifols has stated its intention to resume operations as soon as possible, in coordination with Health Canada and Canadian Blood Services, while assuring the public that Canada's overall blood and plasma supply remains secure. However, the Manitoba Health Coalition and other groups are pushing for a permanent ban on paid plasma collection, raising a national debate about ethics, safety, and the commercialization of human biological products. The coming weeks will see continued scrutiny from Health Canada, and the outcome could reshape the future of plasma donation in Canada.